A Socio-ecological Approach for Improving Self-management in Adolescents With SCD (NCT06290401)
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to evaluate the impact of SCThrive (a behavioral self-management intervention) on patient activation, self-management behaviors, daily functioning, and emergency room visits in 260 adolescents and young adults with sickle cell disease (SCD) ages 13-21 receiving care at 1 of 4 pediatric SCD clinics. The main question\[s\]it aims to answer are: * Does SCThrive improve patient activation? * Does SCThrive improve self-management behaviors, daily functioning, and decrease emergency room visits? * Are any improvements maintained 3 months after treatment? Participants will complete self-management related surveys before, after, and 3 months following their participation in an 8- week, virtual group intervention with an accompanying mobile app (SCThrive). Researchers will compare outcomes for participants who receive SCThrive and participants who receive uniform standard care (SCHealthED which = standard of care plus SCD educational text messages) to see if there are differences in patient activation, self-management behaviors, daily functioning, and emergency room visits.
Who can join: Review the eligibility criteria below.
Location: Nemours Children's Health — Wilmington, Delaware
Age range: 13 Years to 21 Years
🧪 Interventions in This Study
- SCThrive (BEHAVIORAL)
- SCHealthED (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (4 Sites)
- Nemours Children's Health — Wilmington, Delaware
- Children's Healthcare of Atlanta — Atlanta, Georgia
- Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio
- Children's Hospital of Philadelphia — Philadelphia, Pennsylvania
📞 Contact the Study Coordinator
Phone: (513) 636-5380
Email: Ama.Wilson@cchmc.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Anemia, Sickle Cell
- Epidemiology of Silent and Overt Strokes in Sickle Cell Disease — Birmingham, Alabama
- Therapeutic Response Evaluation and Adherence Trial (TREAT) — Cincinnati, Ohio
- A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease — Birmingham, Alabama
Explore by condition: All Anemia, Sickle Cell clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.